NFKBIA Deletion in Glioblastomas

This study shows that the tumor-suppressor gene NFKBIA is deleted in glioblastomas and suggests a degree of mutual exclusivity between these deletions and amplification of EGFR in these tumors. Both NFKBIA deletion and EGFR amplification are associated with poor survival. Glioblastoma multiforme is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2011-02, Vol.364 (7), p.627-637
Hauptverfasser: Bredel, Claudia, Bredel, Markus, Scholtens, Denise M, Yadav, Ajay K, Alvarez, Angel A, Renfrow, Jaclyn J, Chandler, James P, Yu, Irene L.Y, Carro, Maria S, Dai, Fangping, Tagge, Michael J, Ferrarese, Roberto, Phillips, Heidi S, Lukac, Paul J, Robe, Pierre A, Weyerbrock, Astrid, Vogel, Hannes, Dubner, Steven, Mobley, Bret, He, Xiaolin, Scheck, Adrienne C, Sikic, Branimir I, Aldape, Kenneth D, Chakravarti, Arnab, Harsh, Griffith R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 637
container_issue 7
container_start_page 627
container_title The New England journal of medicine
container_volume 364
creator Bredel, Claudia
Bredel, Markus
Scholtens, Denise M
Yadav, Ajay K
Alvarez, Angel A
Renfrow, Jaclyn J
Chandler, James P
Yu, Irene L.Y
Carro, Maria S
Dai, Fangping
Tagge, Michael J
Ferrarese, Roberto
Phillips, Heidi S
Lukac, Paul J
Robe, Pierre A
Weyerbrock, Astrid
Vogel, Hannes
Dubner, Steven
Mobley, Bret
He, Xiaolin
Scheck, Adrienne C
Sikic, Branimir I
Aldape, Kenneth D
Chakravarti, Arnab
Harsh, Griffith R
description This study shows that the tumor-suppressor gene NFKBIA is deleted in glioblastomas and suggests a degree of mutual exclusivity between these deletions and amplification of EGFR in these tumors. Both NFKBIA deletion and EGFR amplification are associated with poor survival. Glioblastoma multiforme is the most common and most deadly primary brain tumor. 1 It is a complex disease, in which many signaling pathways are disrupted. 2 – 7 Almost all glioblastomas have excessive activation of the epidermal growth factor receptor (EGFR) pathway, 8 often brought about by amplification (see the Glossary for this and other key terms) or activating mutations of the EGFR oncogene. 9 Alternative mechanisms of the activation of the EGFR pathway may exist in tumors that do not have alterations of EGFR . Nuclear factor of κ-light polypeptide gene enhancer in B-cells (NF-κB) is a transcription factor activated by the EGFR pathway. . . .
doi_str_mv 10.1056/NEJMoa1006312
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3652611</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2358412191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-a8302bde6b6f170b9b373118883b11d4fc4e8e12753bfbb3008879285e3ab193</originalsourceid><addsrcrecordid>eNp1kUlPwzAQhS0EglI4ckUVEseAx-M4zgWJtexcuFt26hRXSQx2isS_x9CyHZiLR_I3781CyA7QA6C5OLw_v77zGigVCGyFDCBHzDinYpUMKGUy40WJG2QzxhlNAbxcJxsMoMiR8gEZ3V_cnFwdj85sY3vnu5HrRuPGedPo2PtWxy2yVusm2u3lOySPF-ePp5fZ7cP46vT4NqtyBn2mJVJmJlYYUUNBTWmwQAApJRqACa8rbqUFlmxNbQxSKmVRMplb1AZKHJKjhezz3LR2UtmuD7pRz8G1Orwpr536-9O5JzX1rwpFzgRAEmALgcbZqVU-GKde2WfhZz5vpkpXyljFmJBKckSeivaWrsG_zG3s1czPQ5fmVFJIkVZKMUHZAqqCjzHY-rsroOrjBurPDRK_-3uUb_pr6QnYXwI6Vrqpg-4qF384lIJzXvxwbRtVZ2ftP4bvuU-Xbw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>868663103</pqid></control><display><type>article</type><title>NFKBIA Deletion in Glioblastomas</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Bredel, Claudia ; Bredel, Markus ; Scholtens, Denise M ; Yadav, Ajay K ; Alvarez, Angel A ; Renfrow, Jaclyn J ; Chandler, James P ; Yu, Irene L.Y ; Carro, Maria S ; Dai, Fangping ; Tagge, Michael J ; Ferrarese, Roberto ; Phillips, Heidi S ; Lukac, Paul J ; Robe, Pierre A ; Weyerbrock, Astrid ; Vogel, Hannes ; Dubner, Steven ; Mobley, Bret ; He, Xiaolin ; Scheck, Adrienne C ; Sikic, Branimir I ; Aldape, Kenneth D ; Chakravarti, Arnab ; Harsh, Griffith R</creator><creatorcontrib>Bredel, Claudia ; Bredel, Markus ; Scholtens, Denise M ; Yadav, Ajay K ; Alvarez, Angel A ; Renfrow, Jaclyn J ; Chandler, James P ; Yu, Irene L.Y ; Carro, Maria S ; Dai, Fangping ; Tagge, Michael J ; Ferrarese, Roberto ; Phillips, Heidi S ; Lukac, Paul J ; Robe, Pierre A ; Weyerbrock, Astrid ; Vogel, Hannes ; Dubner, Steven ; Mobley, Bret ; He, Xiaolin ; Scheck, Adrienne C ; Sikic, Branimir I ; Aldape, Kenneth D ; Chakravarti, Arnab ; Harsh, Griffith R</creatorcontrib><description>This study shows that the tumor-suppressor gene NFKBIA is deleted in glioblastomas and suggests a degree of mutual exclusivity between these deletions and amplification of EGFR in these tumors. Both NFKBIA deletion and EGFR amplification are associated with poor survival. Glioblastoma multiforme is the most common and most deadly primary brain tumor. 1 It is a complex disease, in which many signaling pathways are disrupted. 2 – 7 Almost all glioblastomas have excessive activation of the epidermal growth factor receptor (EGFR) pathway, 8 often brought about by amplification (see the Glossary for this and other key terms) or activating mutations of the EGFR oncogene. 9 Alternative mechanisms of the activation of the EGFR pathway may exist in tumors that do not have alterations of EGFR . Nuclear factor of κ-light polypeptide gene enhancer in B-cells (NF-κB) is a transcription factor activated by the EGFR pathway. . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>ISSN: 1533-4406</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa1006312</identifier><identifier>PMID: 21175304</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Waltham, MA: Massachusetts Medical Society</publisher><subject>Biological and medical sciences ; Cancer ; DNA Mutational Analysis ; Gene Amplification ; Gene Deletion ; Gene Expression ; General aspects ; Genes ; Genes, erbB-1 ; Genetics &amp; genetic processes ; Glioblastoma - genetics ; Glioblastoma - mortality ; Génétique &amp; processus génétiques ; Humans ; I-kappa B Proteins - genetics ; Kaplan-Meier Estimate ; Life sciences ; Medical sciences ; Mutation ; Neurology ; NF-KappaB Inhibitor alpha ; Prognosis ; Proteins ; Sciences du vivant ; Tumor Cells, Cultured ; Tumors ; Tumors of the nervous system. Phacomatoses</subject><ispartof>The New England journal of medicine, 2011-02, Vol.364 (7), p.627-637</ispartof><rights>Copyright © 2011 Massachusetts Medical Society. All rights reserved.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Massachusetts Medical Society. 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-a8302bde6b6f170b9b373118883b11d4fc4e8e12753bfbb3008879285e3ab193</citedby><cites>FETCH-LOGICAL-c521t-a8302bde6b6f170b9b373118883b11d4fc4e8e12753bfbb3008879285e3ab193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa1006312$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/868663103?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,777,781,882,2746,2747,26084,27905,27906,52363,54045,64364,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23864447$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21175304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bredel, Claudia</creatorcontrib><creatorcontrib>Bredel, Markus</creatorcontrib><creatorcontrib>Scholtens, Denise M</creatorcontrib><creatorcontrib>Yadav, Ajay K</creatorcontrib><creatorcontrib>Alvarez, Angel A</creatorcontrib><creatorcontrib>Renfrow, Jaclyn J</creatorcontrib><creatorcontrib>Chandler, James P</creatorcontrib><creatorcontrib>Yu, Irene L.Y</creatorcontrib><creatorcontrib>Carro, Maria S</creatorcontrib><creatorcontrib>Dai, Fangping</creatorcontrib><creatorcontrib>Tagge, Michael J</creatorcontrib><creatorcontrib>Ferrarese, Roberto</creatorcontrib><creatorcontrib>Phillips, Heidi S</creatorcontrib><creatorcontrib>Lukac, Paul J</creatorcontrib><creatorcontrib>Robe, Pierre A</creatorcontrib><creatorcontrib>Weyerbrock, Astrid</creatorcontrib><creatorcontrib>Vogel, Hannes</creatorcontrib><creatorcontrib>Dubner, Steven</creatorcontrib><creatorcontrib>Mobley, Bret</creatorcontrib><creatorcontrib>He, Xiaolin</creatorcontrib><creatorcontrib>Scheck, Adrienne C</creatorcontrib><creatorcontrib>Sikic, Branimir I</creatorcontrib><creatorcontrib>Aldape, Kenneth D</creatorcontrib><creatorcontrib>Chakravarti, Arnab</creatorcontrib><creatorcontrib>Harsh, Griffith R</creatorcontrib><title>NFKBIA Deletion in Glioblastomas</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>This study shows that the tumor-suppressor gene NFKBIA is deleted in glioblastomas and suggests a degree of mutual exclusivity between these deletions and amplification of EGFR in these tumors. Both NFKBIA deletion and EGFR amplification are associated with poor survival. Glioblastoma multiforme is the most common and most deadly primary brain tumor. 1 It is a complex disease, in which many signaling pathways are disrupted. 2 – 7 Almost all glioblastomas have excessive activation of the epidermal growth factor receptor (EGFR) pathway, 8 often brought about by amplification (see the Glossary for this and other key terms) or activating mutations of the EGFR oncogene. 9 Alternative mechanisms of the activation of the EGFR pathway may exist in tumors that do not have alterations of EGFR . Nuclear factor of κ-light polypeptide gene enhancer in B-cells (NF-κB) is a transcription factor activated by the EGFR pathway. . . .</description><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>DNA Mutational Analysis</subject><subject>Gene Amplification</subject><subject>Gene Deletion</subject><subject>Gene Expression</subject><subject>General aspects</subject><subject>Genes</subject><subject>Genes, erbB-1</subject><subject>Genetics &amp; genetic processes</subject><subject>Glioblastoma - genetics</subject><subject>Glioblastoma - mortality</subject><subject>Génétique &amp; processus génétiques</subject><subject>Humans</subject><subject>I-kappa B Proteins - genetics</subject><subject>Kaplan-Meier Estimate</subject><subject>Life sciences</subject><subject>Medical sciences</subject><subject>Mutation</subject><subject>Neurology</subject><subject>NF-KappaB Inhibitor alpha</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>Sciences du vivant</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Tumors of the nervous system. Phacomatoses</subject><issn>0028-4793</issn><issn>1533-4406</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kUlPwzAQhS0EglI4ckUVEseAx-M4zgWJtexcuFt26hRXSQx2isS_x9CyHZiLR_I3781CyA7QA6C5OLw_v77zGigVCGyFDCBHzDinYpUMKGUy40WJG2QzxhlNAbxcJxsMoMiR8gEZ3V_cnFwdj85sY3vnu5HrRuPGedPo2PtWxy2yVusm2u3lOySPF-ePp5fZ7cP46vT4NqtyBn2mJVJmJlYYUUNBTWmwQAApJRqACa8rbqUFlmxNbQxSKmVRMplb1AZKHJKjhezz3LR2UtmuD7pRz8G1Orwpr536-9O5JzX1rwpFzgRAEmALgcbZqVU-GKde2WfhZz5vpkpXyljFmJBKckSeivaWrsG_zG3s1czPQ5fmVFJIkVZKMUHZAqqCjzHY-rsroOrjBurPDRK_-3uUb_pr6QnYXwI6Vrqpg-4qF384lIJzXvxwbRtVZ2ftP4bvuU-Xbw</recordid><startdate>20110217</startdate><enddate>20110217</enddate><creator>Bredel, Claudia</creator><creator>Bredel, Markus</creator><creator>Scholtens, Denise M</creator><creator>Yadav, Ajay K</creator><creator>Alvarez, Angel A</creator><creator>Renfrow, Jaclyn J</creator><creator>Chandler, James P</creator><creator>Yu, Irene L.Y</creator><creator>Carro, Maria S</creator><creator>Dai, Fangping</creator><creator>Tagge, Michael J</creator><creator>Ferrarese, Roberto</creator><creator>Phillips, Heidi S</creator><creator>Lukac, Paul J</creator><creator>Robe, Pierre A</creator><creator>Weyerbrock, Astrid</creator><creator>Vogel, Hannes</creator><creator>Dubner, Steven</creator><creator>Mobley, Bret</creator><creator>He, Xiaolin</creator><creator>Scheck, Adrienne C</creator><creator>Sikic, Branimir I</creator><creator>Aldape, Kenneth D</creator><creator>Chakravarti, Arnab</creator><creator>Harsh, Griffith R</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>Q33</scope><scope>5PM</scope></search><sort><creationdate>20110217</creationdate><title>NFKBIA Deletion in Glioblastomas</title><author>Bredel, Claudia ; Bredel, Markus ; Scholtens, Denise M ; Yadav, Ajay K ; Alvarez, Angel A ; Renfrow, Jaclyn J ; Chandler, James P ; Yu, Irene L.Y ; Carro, Maria S ; Dai, Fangping ; Tagge, Michael J ; Ferrarese, Roberto ; Phillips, Heidi S ; Lukac, Paul J ; Robe, Pierre A ; Weyerbrock, Astrid ; Vogel, Hannes ; Dubner, Steven ; Mobley, Bret ; He, Xiaolin ; Scheck, Adrienne C ; Sikic, Branimir I ; Aldape, Kenneth D ; Chakravarti, Arnab ; Harsh, Griffith R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-a8302bde6b6f170b9b373118883b11d4fc4e8e12753bfbb3008879285e3ab193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>DNA Mutational Analysis</topic><topic>Gene Amplification</topic><topic>Gene Deletion</topic><topic>Gene Expression</topic><topic>General aspects</topic><topic>Genes</topic><topic>Genes, erbB-1</topic><topic>Genetics &amp; genetic processes</topic><topic>Glioblastoma - genetics</topic><topic>Glioblastoma - mortality</topic><topic>Génétique &amp; processus génétiques</topic><topic>Humans</topic><topic>I-kappa B Proteins - genetics</topic><topic>Kaplan-Meier Estimate</topic><topic>Life sciences</topic><topic>Medical sciences</topic><topic>Mutation</topic><topic>Neurology</topic><topic>NF-KappaB Inhibitor alpha</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>Sciences du vivant</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Tumors of the nervous system. Phacomatoses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bredel, Claudia</creatorcontrib><creatorcontrib>Bredel, Markus</creatorcontrib><creatorcontrib>Scholtens, Denise M</creatorcontrib><creatorcontrib>Yadav, Ajay K</creatorcontrib><creatorcontrib>Alvarez, Angel A</creatorcontrib><creatorcontrib>Renfrow, Jaclyn J</creatorcontrib><creatorcontrib>Chandler, James P</creatorcontrib><creatorcontrib>Yu, Irene L.Y</creatorcontrib><creatorcontrib>Carro, Maria S</creatorcontrib><creatorcontrib>Dai, Fangping</creatorcontrib><creatorcontrib>Tagge, Michael J</creatorcontrib><creatorcontrib>Ferrarese, Roberto</creatorcontrib><creatorcontrib>Phillips, Heidi S</creatorcontrib><creatorcontrib>Lukac, Paul J</creatorcontrib><creatorcontrib>Robe, Pierre A</creatorcontrib><creatorcontrib>Weyerbrock, Astrid</creatorcontrib><creatorcontrib>Vogel, Hannes</creatorcontrib><creatorcontrib>Dubner, Steven</creatorcontrib><creatorcontrib>Mobley, Bret</creatorcontrib><creatorcontrib>He, Xiaolin</creatorcontrib><creatorcontrib>Scheck, Adrienne C</creatorcontrib><creatorcontrib>Sikic, Branimir I</creatorcontrib><creatorcontrib>Aldape, Kenneth D</creatorcontrib><creatorcontrib>Chakravarti, Arnab</creatorcontrib><creatorcontrib>Harsh, Griffith R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Université de Liège - Open Repository and Bibliography (ORBI)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bredel, Claudia</au><au>Bredel, Markus</au><au>Scholtens, Denise M</au><au>Yadav, Ajay K</au><au>Alvarez, Angel A</au><au>Renfrow, Jaclyn J</au><au>Chandler, James P</au><au>Yu, Irene L.Y</au><au>Carro, Maria S</au><au>Dai, Fangping</au><au>Tagge, Michael J</au><au>Ferrarese, Roberto</au><au>Phillips, Heidi S</au><au>Lukac, Paul J</au><au>Robe, Pierre A</au><au>Weyerbrock, Astrid</au><au>Vogel, Hannes</au><au>Dubner, Steven</au><au>Mobley, Bret</au><au>He, Xiaolin</au><au>Scheck, Adrienne C</au><au>Sikic, Branimir I</au><au>Aldape, Kenneth D</au><au>Chakravarti, Arnab</au><au>Harsh, Griffith R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NFKBIA Deletion in Glioblastomas</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2011-02-17</date><risdate>2011</risdate><volume>364</volume><issue>7</issue><spage>627</spage><epage>637</epage><pages>627-637</pages><issn>0028-4793</issn><issn>1533-4406</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>This study shows that the tumor-suppressor gene NFKBIA is deleted in glioblastomas and suggests a degree of mutual exclusivity between these deletions and amplification of EGFR in these tumors. Both NFKBIA deletion and EGFR amplification are associated with poor survival. Glioblastoma multiforme is the most common and most deadly primary brain tumor. 1 It is a complex disease, in which many signaling pathways are disrupted. 2 – 7 Almost all glioblastomas have excessive activation of the epidermal growth factor receptor (EGFR) pathway, 8 often brought about by amplification (see the Glossary for this and other key terms) or activating mutations of the EGFR oncogene. 9 Alternative mechanisms of the activation of the EGFR pathway may exist in tumors that do not have alterations of EGFR . Nuclear factor of κ-light polypeptide gene enhancer in B-cells (NF-κB) is a transcription factor activated by the EGFR pathway. . . .</abstract><cop>Waltham, MA</cop><pub>Massachusetts Medical Society</pub><pmid>21175304</pmid><doi>10.1056/NEJMoa1006312</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2011-02, Vol.364 (7), p.627-637
issn 0028-4793
1533-4406
1533-4406
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3652611
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Biological and medical sciences
Cancer
DNA Mutational Analysis
Gene Amplification
Gene Deletion
Gene Expression
General aspects
Genes
Genes, erbB-1
Genetics & genetic processes
Glioblastoma - genetics
Glioblastoma - mortality
Génétique & processus génétiques
Humans
I-kappa B Proteins - genetics
Kaplan-Meier Estimate
Life sciences
Medical sciences
Mutation
Neurology
NF-KappaB Inhibitor alpha
Prognosis
Proteins
Sciences du vivant
Tumor Cells, Cultured
Tumors
Tumors of the nervous system. Phacomatoses
title NFKBIA Deletion in Glioblastomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A10%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NFKBIA%20Deletion%20in%20Glioblastomas&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Bredel,%20Claudia&rft.date=2011-02-17&rft.volume=364&rft.issue=7&rft.spage=627&rft.epage=637&rft.pages=627-637&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJMoa1006312&rft_dat=%3Cproquest_pubme%3E2358412191%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=868663103&rft_id=info:pmid/21175304&rfr_iscdi=true